{"transactions":[{"id":955279,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70598,"kind":"person","name":"Winter Charles M.","position":1,"cik":"0001960264","reported_name":"Winter Charles M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-01-03T02:00:12.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":100100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":100100,"derivative":{"exercise_price":13.65,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":100100},"source":{"system":"sec-edgar","filing":"0001960264-26-000002","document":"form4-01022026_090107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000196026426000002/form4-01022026_090107.xml","form_type":"4"}},{"id":955278,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70598,"kind":"person","name":"Winter Charles M.","position":1,"cik":"0001960264","reported_name":"Winter Charles M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-01-03T02:00:12.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":28600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027."}],"balance_after":106321,"source":{"system":"sec-edgar","filing":"0001960264-26-000002","document":"form4-01022026_090107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000196026426000002/form4-01022026_090107.xml","form_type":"4"}},{"id":955277,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70598,"kind":"person","name":"Winter Charles M.","position":1,"cik":"0001960264","reported_name":"Winter Charles M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-01-03T02:00:12.000Z","date":"2026-01-02","kind":"sale","planned":false,"acquired":false,"shares":2401,"price":13.73,"value":32965.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,834 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on May 15, 2025."}],"balance_after":77721,"source":{"system":"sec-edgar","filing":"0001960264-26-000002","document":"form4-01022026_090107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000196026426000002/form4-01022026_090107.xml","form_type":"4"}},{"id":1315115,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70598,"kind":"person","name":"Winter Charles M.","position":1,"cik":"0001960264","reported_name":"Winter Charles M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-01-04T01:10:12.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":80500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on January 1, 2026 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":80500,"derivative":{"exercise_price":53.24,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":80500},"source":{"system":"sec-edgar","filing":"0001415889-25-000676","document":"form4-01032025_080109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588925000676/form4-01032025_080109.xml","form_type":"4"}},{"id":1315114,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70598,"kind":"person","name":"Winter Charles M.","position":1,"cik":"0001960264","reported_name":"Winter Charles M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-01-04T01:10:12.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,297 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the \"Plan\") on November 15, 2021, 1,644 shares acquired under the Plan on May 13, 2022, 2,401 shares acquired under the Plan on May 15, 2023, 2,834 shares acquired under the Plan on May 15, 2024 and 1 share acquired under the Plan on November 15, 2024."}],"balance_after":77288,"source":{"system":"sec-edgar","filing":"0001415889-25-000676","document":"form4-01032025_080109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588925000676/form4-01032025_080109.xml","form_type":"4"}},{"id":1693013,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70598,"kind":"person","name":"Winter Charles M.","position":1,"cik":"0001960264","reported_name":"Winter Charles M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T21:54:44.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":111000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on January 1, 2025 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":111000,"derivative":{"exercise_price":11.02,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":111000},"source":{"system":"sec-edgar","filing":"0001209191-24-000440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000120919124000440/doc4.xml","form_type":"4"}},{"id":2063011,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70598,"kind":"person","name":"Winter Charles M.","position":1,"cik":"0001960264","reported_name":"Winter Charles M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T21:36:59.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on January 1, 2024 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":100000,"derivative":{"exercise_price":14.02,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-001886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000120919123001886/doc4.xml","form_type":"4"}}]}